- Home
- NVCT vs ESSA Comparison
NVCT vs ESSA Comparison
Compare NVCT & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- ESSA
- Stock Information
- Founded
- NVCT 2020
- ESSA 1916
- Country
- NVCT United States
- ESSA United States
- Employees
- NVCT N/A
- ESSA N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- ESSA Banks
- Sector
- NVCT Health Care
- ESSA Finance
- Exchange
- NVCT Nasdaq
- ESSA Nasdaq
- Market Cap
- NVCT 184.9M
- ESSA 207.7M
- IPO Year
- NVCT 2022
- ESSA N/A
- Fundamental
- Price
- NVCT $7.78
- ESSA $20.61
- Analyst Decision
- NVCT Strong Buy
- ESSA
- Analyst Count
- NVCT 3
- ESSA 0
- Target Price
- NVCT $17.00
- ESSA N/A
- AVG Volume (30 Days)
- NVCT 265.7K
- ESSA 98.3K
- Earning Date
- NVCT 08-05-2025
- ESSA 08-05-2025
- Dividend Yield
- NVCT N/A
- ESSA 2.91%
- EPS Growth
- NVCT N/A
- ESSA N/A
- EPS
- NVCT N/A
- ESSA 1.55
- Revenue
- NVCT N/A
- ESSA $66,345,000.00
- Revenue This Year
- NVCT N/A
- ESSA $9.38
- Revenue Next Year
- NVCT N/A
- ESSA N/A
- P/E Ratio
- NVCT N/A
- ESSA $13.31
- Revenue Growth
- NVCT N/A
- ESSA N/A
- 52 Week Low
- NVCT $4.44
- ESSA $15.82
- 52 Week High
- NVCT $11.80
- ESSA $22.22
- Technical
- Relative Strength Index (RSI)
- NVCT 44.12
- ESSA 60.86
- Support Level
- NVCT $7.70
- ESSA $19.58
- Resistance Level
- NVCT $8.24
- ESSA $21.07
- Average True Range (ATR)
- NVCT 0.44
- ESSA 0.52
- MACD
- NVCT 0.03
- ESSA -0.04
- Stochastic Oscillator
- NVCT 27.52
- ESSA 69.13
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.